• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT B-HCG CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT B-HCG CARTRIDGE Back to Search Results
Catalog Number 05P58-25
Device Problem False Positive Result (1227)
Patient Problems Anxiety (2328); Lymphoma (3263)
Event Date 02/29/2024
Event Type  malfunction  
Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling was evaluated during the investigation as pertaining to the event.
 
Event Description
On 08-mar-2024, abbott point of care (apoc) was contacted by a customer regarding i-stat b-hcg cartridges that yielded positive results on a 28 year female patient.Return product is not available for investigation.Method; date, collected, tested, result, and sample.I-stat; (b)(6) 2024, immediately, 15:23, 39.3 iu/l, and a.Lab, (b)(6) 2024, 15:57, 18:54, <1, and b.There are no injuries associated with this event.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The investigation is underway.I-stat positive cut-off values: b-hcg < 5.0 iu/l; negative.5.0 < ss-hcg < 25.0 iu/l; indeterminate.B-hcg >25.0 iu/l; positive.Intended use: the i-stat® total beta-human chorionic gonadotropin (b-hcg) test is an in vitro diagnostic test for the quantitative and qualitative determination of b-hcg in venous whole blood or plasma samples using the i-stat 1 analyzer systems.The test is intended to be used as an aid in the early detection of pregnancy and is for prescription use only.
 
Event Description
Na.
 
Manufacturer Narrative
Apoc incident: # (b)(4).The investigation was completed on 29-apr-2024.The customer observed a high result from total b-hcg cartridge lot f23265 that was considered discrepant from the laboratory instrument result.A review of the device history record confirmed the cartridge lot met finished goods release criteria.Retained cartridge testing met the acceptance criteria outlined in appendix 1 of q04.01.003 rev.An (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified for total b-hcg cartridge lot f23265.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT B-HCG CARTRIDGE
Type of Device
B-HCG CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
Manufacturer (Section G)
ABBOTT POINT OF CARE CANADA LTD.
185 corkstown road
K2H 8 V4
CA   K2H 8V4
Manufacturer Contact
linda maczuszenko
185 corkstown road
princeton, NJ K2H 8-V4
CA   K2H 8V4
6136123525
MDR Report Key18934397
MDR Text Key338307144
Report Number2245578-2024-00058
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K133002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/19/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/07/2024
Device Catalogue Number05P58-25
Device Lot NumberF23265
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/29/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age23 YR
Patient SexFemale
-
-